{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Namita%20A.%20Goyal%2C%20M.D.","name":"Namita A. Goyal, M.D.","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-06T02:30:27.179Z"},"count":1,"matches":[{"id":"e2fdad054bcc7286","posted_date":"2024-10-22","letter_issue_date":"2024-10-10","company_name":"Namita A. Goyal, M.D.","issuing_office":"Center for Biologics Evaluation and Research (CBER)","subject":"Clinical Investigator","canonical_url":"https://api.morvs.ai/fda-warning/e2fdad054bcc7286"}]}